A Study to Evaluate the Safety and Bridging PK Profile of FB825 for Single Subcutaneous Administration in Healthy Adults
Clinical trial NCT05952986 · UNKNOWN
Trial details
- NCT number
- NCT05952986
- Sponsor
- Oneness Biotech Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-03
- Primary completion
- 2024-03-26
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.